:: Islet Sciences | Welcome | Type 1 diabetes | Treat | Prevent | Cure | BiotechWww.isletsciences.com
Across the U.S., type 1 diabetes is on the rise. Hispanic and Black communities are affected more than others. For instance, studies show that if you have brown or black skin, controlling your blood glucose once you're diagnosed is more of a challenge. Black children with type 1 diabetes...
They say, that there is a vaccine that can not only halt type 1 diabetes in its tracks but also that it has the ability to reverse the condition. When I first read about this vaccine, it really did sound too good to be true. Could it be the cure we’ve all been waiting for?… ...
Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunotherapy that targets T cells as a means to de...
There’s no cure for diabetes. But with treatment and lifestyle changes, you can live a long, healthy life. Diabetes comes in different forms, depending on the cause. Prediabetes Prediabetes is when your blood sugar is higher than it should be but not high enough for your doctor to diagn...
Type 1 diabetes is a common, severe chronic autoimmune disease that is characterized by the progressive and insidious loss of self-tolerance to the insulin-producing pancreatic islet β-cells. This loss of self-tolerance leads to the destruction of β-cells and the development of overt hyperglycaem...
The American Diabetes Association® published updates to the Standards of Care in Diabetes—2023 on the use of teplizumab in delaying the onset of type 1 diabetes.
Beta Cells From Stem Cells: Nearing a Cure for Type 1 Diabetes? Anne L. Peters, MD Disclosures June 28, 2023 5 118 00:00 / 04:13 This transcript has been edited for clarity. Those of us in the field of diabetes have long wanted to curetype 1 diabetes, and there are little steps ...
Clinical studies on the treatment of type 1 diabetes with device-encapsulated pancreatic precursor cells derived from human embryonic stem cells found that insulin output was insufficient for clinical benefit. We are conducting a phase 1/2, open-label, m
s tissues – in the case of type 1 diabetes, pancreatic islets – and by inducing production of regulatory T cells (T-regs) that could prevent an autoimmune reaction. Dr Faustman’s team first reported in 2001 that inducing TNF production could cure type 1 diabetes in mice, but since TNF...